If you pre-order an item and the price drops before the release date, you’ll pay the lowest price. This happens automatically when you pre-order and pay by credit card or pickup.
If paying by PayPal or internet banking, and the price drops after you have paid, you can ask for the difference to be refunded. Find out more
If Mighty Ape's price changes before release, you'll pay the lowest price.
This product will be released on
It should arrive:
- 9-13 November using standard courier delivery
Dr. Ravi Durvasula is Chief of Infectious Diseases, Director of The Center for Global Health and Professor of Medicine at University of New Mexico School of Medicine. For nearly 15 years, Dr. Durvasula has been developing paratransgenic methods for control of important arthropod-borne infectious diseases. Dr. Durvasula's lab has developed novel control systems using engineered symbiotic and commensal bacteria of arthropods. His work on triatomine bug vectors of Chagas disease has been funded through NIH RO1 grants and he is currently establishing collaborative ties for validation of the approach in Argentina. Through a series of grants from the US Department of Agriculture, Dr. Durvasula's group has developed paratransgenic strategies to reduce transmission of plant pathogens via the pest arthropod, Glassy Winged Sharpshooter. In collaboration with investigators in India, Tunisia and Iran, the Durvasula group is developing paratransgenic approaches to control of transmission of leishmania parasites by sand flies. Through the Center for Global Health at University of New Mexico School of Medicine, Dr. Durvasula maintains active collaborations across the globe, to further both research programs and clinical exchange with the United States. The author of over 100 manuscripts, book chapters and conference abstracts, Dr. Durvasula is widely recognized for his contributions to infectious diseases and, in particular, vector-borne diseases. In 2009, he was elected to The American Society for Clinical Investigation and he serves on numerous Study Sections of The National Institutes of Health, Department of Defense and The Burroughs Wellcome Foundation. Scott Matthews has worked in the laboratory of Ravi V. Durvasula since 2002. His work in paratransgenesis is extensive and includes development of the first risk assessment framework for paratransgenesis. He received a Master of Public Health degree from Yale University and is scheduled to graduate as an M. D. from the University of New Mexico School of Medicine in May of 2015.
Nobody has previewed this product yet. You could be the first!Write a Preview
- If you think we've made a mistake or omitted details, please send us your feedback. Send Feedback
- If you have a question or problem with this product, visit our Help section. Get Help
- Seen a lower price for this product elsewhere? We'll do our best to beat it. Request a better price
Buy this and earn 2,991 Banana Points